Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B

2007 ◽  
Vol 22 (10) ◽  
pp. 1582-1588 ◽  
Author(s):  
Themistoklis Vassiliadis ◽  
Konstantinos Tziomalos ◽  
Kalliopi Patsiaoura ◽  
Thomas Zagris ◽  
Olga Giouleme ◽  
...  
2007 ◽  
Vol 51 (8) ◽  
pp. 3020-3022 ◽  
Author(s):  
Sabahattin Kaymakoglu ◽  
Dilek Oguz ◽  
Gurden Gur ◽  
Selim Gurel ◽  
Ethem Tankurt ◽  
...  

ABSTRACT Forty-eight hepatitis B virus (HBV) E antigen-negative chronic hepatitis B patients received pegylated interferon alfa-2b either alone or with lamivudine for 48 weeks and were followed for an additional 24 weeks. At the end of follow-up, virological response rates (HBV DNA levels of <400 copies/ml) were similar in the monotherapy (24%) and combination therapy (26%) groups.


2013 ◽  
Vol 13 (11) ◽  
Author(s):  
Meisam Mahdavi ◽  
Houshang Amirrasouli ◽  
Seyed Moayed Alavian ◽  
Bita Behnava ◽  
Faranak Kazerouni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document